Literature DB >> 11098057

Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope.

M David1, D B Borza, A Leinonen, J M Belmont, B G Hudson.   

Abstract

Goodpasture (GP) autoimmune disease is caused by autoantibodies to type IV collagen that bind to the glomerular basement membrane, causing rapidly progressing glomerulonephritis. The immunodominant GP(A) autoepitope is encompassed by residues 17-31 (the E(A) region) within the noncollagenous (NC1) domain of the alpha 3(IV) chain. The GP epitope is cryptic in the NC1 hexamer complex that occurs in the type IV collagen network found in tissues and inaccessible to autoantibodies unless the hexamer dissociates. In contrast, the epitope for the Mab3 monoclonal antibody is also located within the E(A) region, but is fully accessible in the hexamer complex. In this study, the identity of residues that compose the GP(A) autoepitope was determined, and the molecular basis of its cryptic nature was explored. This was achieved using site-directed mutagenesis to exchange the alpha3(IV) residues in the E(A) region with the corresponding residues of the homologous but non-immunoreactive alpha1(IV) NC1 domain and then comparing the reactivity of the mutated chimeras with GP(A) and Mab3 antibodies. It was shown that three hydrophobic residues (Ala(18), Ile(19), and Val(27)) and Pro(28) are critical for the GP(A) autoepitope, whereas two hydrophilic residues (Ser(21) and Ser(31)) along with Pro(28) are critical for the Mab3 epitope. These results suggest that the cryptic nature of the GP(A) autoepitope is the result of quaternary interactions of the alpha 3, alpha 4, and alpha 5 NC1 domains of the hexamer complex that bury the one or more hydrophobic residues. These findings provide critical information for understanding the etiology and pathogenesis of the disease as well as for designing drugs that would mimic the epitope and thus block the binding of GP autoantibodies to autoantigen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098057     DOI: 10.1074/jbc.M008956200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Basement membrane collagen IV: Isolation of functional domains.

Authors:  Sergei P Boudko; Neonila Danylevych; Billy G Hudson; Vadim K Pedchenko
Journal:  Methods Cell Biol       Date:  2017-11-06       Impact factor: 1.441

2.  Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; J Haxby; J K Juggapah; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

Review 3.  Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.

Authors:  Vadim Pedchenko; Roberto Vanacore; Billy Hudson
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

Review 4.  Sulphilimine cross-links in Goodpasture's disease.

Authors:  R Vanacore; V Pedchenko; G Bhave; B G Hudson
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

5.  Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.

Authors:  Brian A MacDonald; Malin Sund; Marianne A Grant; Kathleen L Pfaff; Kathryn Holthaus; Leonard I Zon; Raghu Kalluri
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

Review 6.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 7.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

Review 8.  Mammalian collagen IV.

Authors:  Jamshid Khoshnoodi; Vadim Pedchenko; Billy G Hudson
Journal:  Microsc Res Tech       Date:  2008-05       Impact factor: 2.769

9.  A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes.

Authors:  Roberto M Vanacore; Amy-Joan L Ham; Jean-Philippe Cartailler; Munirathinam Sundaramoorthy; Parvin Todd; Vadim Pedchenko; Yoshikazu Sado; Dorin-Bogdan Borza; Billy G Hudson
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

10.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.